Hospital stocks including Fortis Healthcare, Dr Agarwal’s, Manipal, Apollo Hospitals and Medanta extended their losses for a second straight session on Thursday, after falling as much as 10% in the previous session, as the Supreme Court questioned steep markups on cancer drugs and asked the government to examine allegations that hospitals require patients to purchase medicines from their own or designated pharmacies.
Fortis Healthcare shares have fallen 10% over the past two sessions, while Apollo Hospitals Enterprises has declined 9% during the same period. Max Healthcare is down 8%, while Dr Agarwal’s has slipped over 1%. Global Health, which operates the Medanta brand, was little changed on Friday.
